Pays: Suisse
Langue: français
Source: Swissmedic (Swiss Agency for Therapeutic Products)
rituximabum
Pfizer AG
L01XC02
rituximabum
Solution à diluer pour Perfusion
rituximabum 500 mg, histidinum, histidini hydrochloridum monohydricum, dinatrii edetas corresp. natrium 0.35 mg, polysorbatum 80, saccharum, aqua ad iniectabilia q.s. ad solutionem pro 50 ml.
A
Biotechnologika
Non-Hodgkin-Lymphom, Rheumatoide Arthritis, ANCA-assoziierte Vaskulitis (AAV)
2020-08-04